Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 001

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2006

Study Completion Date

May 31, 2006

Conditions
Meningitis
Interventions
BIOLOGICAL

Group ACYW135 Meningococcal Polysaccharide Vaccine

60 subjects were divided into three groups (20 subjects each group), adult (16\~30 years of age), early youth (7\~15 years of age) and children (2\~6 years of age) to receive Group ACYW135 Meningococcal Polysaccharide Vaccine, 0.5 ml, one dose regime

All Listed Sponsors
lead

Hualan Biological Engineering, Inc.

INDUSTRY